Financings Of The Fortnight Sees More Conflicting Indicators For Biotech VC
This article was originally published in The Pink Sheet Daily
Executive Summary
Quarterly trends suggest the outlook may turn sunny, plus financings updates on NuPathe, Euthymics Bioscience, Xoma and Immune Design Corp.